Where Care Excellence Meets Business Success. Transform your operations today - 0333 577 0877
Log in to CareSync Interview Preparation.

Would you like to receive update from CareSync Experts?
Summary, notice description and lot information
NHS Lincolnshire Integrated Care Board has announced its intention to award a contract under the Provider Selection Regime for Primary Care Enhanced Services, including general-practitioner services such as phlebotomy and specialised drug monitoring. The contract is set within the healthcare industry category and focuses on the provision of services across the South West locality of Lincolnshire, UK. The process is at the award stage with a standstill period allowing for representations by providers until 8th September 2025.
The contract, valued at £58,297, is planned to run from 1st April 2025 to 31st March 2026. This procurement follows a direct award procedure without prior publication of a call for competition and is governed by the Health Care Services (Provider Selection Regime) Regulations 2023. This tender presents opportunities for businesses, particularly those already involved in healthcare services, to grow by offering enhanced services in primary care.
Those with a track record of quality service delivery and innovation such as existing providers, like Market Cross Surgery, are well-suited to compete. These businesses can leverage their expertise in general-practitioner services to meet the procurement criteria centred on quality, value, integration, and social value, potentially leading to strengthened local healthcare provision and reduced health inequalities. For SMEs looking to expand or enter into contractual agreements with public bodies, engaging in this tender process could lead to significant growth and community impact.
NHS Lincolnshire ICB is intending to utilise direct award process C of the Provider Selection Regime regulations to award a contract for the provision of: Primary Care Enhanced Services, including: - Phlebotomy - Treatment Room - Leg Ulcer - Pessaries - Warfarin - DOAC, Gonadorelins (Zoladex) - Specialised Drug Monitoring - Safeguarding - Minor Injuries - DVT Assessment & Management including D-Dimer Testing - Ambulatory ECG (South West locality only) The contract duration is from 1st April 2025 to 31st March 2026 and the expected value of the activity for the lifetime of the contract is PS58,297 The provider is an existing provider and the services are existing services.
Notice type, method, and CPV codes
Financial information and value estimates
Contract duration information not available.
Publication, submission, and award timeline
Current status of tender, lots, awards, and contracts
Buyer organisation and contact details
Supplier who was awarded this contract
External resources and data downloads
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector.
Our expert team can help you prepare a winning bid. Get professional support from CareSync Experts.
Get in touch with our team at Care Sync Experts today for a consultation.
Email: hello@caresyncexperts.co.uk
Phone: 0333 577 0877
Contact Us